O
OmniAb, Inc. (OABI)
NGM – Real vaqt narxi. Valyuta: USD
1.85
+0.18 (10.78%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
1.85
+0.18 (10.78%)
Yopilishda: May 12, 2026, 4:00 PM EDT
OmniAb, Inc., biotexnologiya kompaniyasi, AQSh, Yevropa, Yaponiya, Xitoy va Kanadada terapevtik vositalarni kashf qilish imkonini berish uchun farmatsevtika va biotexnologiya kompaniyalari hamda akademik muassasalarga kashfiyot tadqiqot texnologiyalarini litsenziyalaydi. Kompaniyaning texnologik platformasi sheriklar uchun dorilarni ishlab chiqish ishlarida optimal antitelalar va boshqa maqsadli oqsillarni aniqlash uchun turli xil antitel repertoarlarini yaratadi va saralaydi. OmniAb platformasining biologik intellekti inson terapevtik vositalari uchun optimallashtirilgan antitel nomzodlarini yaratish uchun o'ziga tegishli va muhandislik qilingan transgen hayvonlarning immunitet tizimlaridan foydalanadi. Kompaniya taklif etadigan hayvonlarga asoslangan texnologiyalar qatoriga inson ketma-ketliklariga ega antitelalar ishlab chiqarish uchun genetik jihatdan o'zgartirilgan OmniRat, OmniChicken va OmniMouse; ikki tomonlama antitelalar kashfiyoti uchun mo'ljallangan ikki tomonlama kalamush va OmniClic, ikki tomonlama tovuq; qiyin maqsadlar uchun noyob tarkibiy xususiyatlarga ega sigir ilhomidagi antitelalarni ta'minlaydigan OmniTaur; inson VH scaffoldiga asoslangan yagona domenli antitelalarni kashf qilish uchun in vivo platformasi bo'lgan OmnidAb; va turli texnologiyalar va imkoniyatlar orqali terapevtik kashfiyot va optimallashtirish uchun sun'iy intellekt (AI) va mashina o'rganish vositalarining in silico to'plami bo'lgan OmniDeep kiradi. Uning OmniAb antitelalarini kashf qilish platformasidan foydalangan holda ishlab chiqarilgan antitelalarga STR texnologiyasini kiritish uchun o'zining Fc-silencing platform texnologiyasi uchun mAbsolve Ltd. bilan kelishuvi bor. OmniAb, Inc. 2012-yilda tashkil etilgan va shtab-kvartirasi Kaliforniyaning Emeryville shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Bill Harriman Ph.D. | Senior Vice President of Antibody Discovery |
| Dr. Bob Chen | Senior Vice President of Discovery Systems |
| Dr. Christel Iffland Ph.D. | Senior Vice President of Antibody Technologies |
| Dr. Yasmina Noubia Abdiche Ph.D. | Senior Vice President of Exploratory Research |
| Mr. Charles S. Berkman J.D. | Chief Legal Officer & Secretary |
| Mr. Kurt A. Gustafson | Executive VP of Finance & CFO |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 8-K | oabi-20260507.htm |
| 2026-04-29 | DEFA14A | a2025proxydefa14aa.htm |
| 2026-03-04 | 10-K | ck0001846253-20251231.htm |
| 2026-01-30 | 8-K | oabi-20260130.htm |
| 2025-11-04 | 10-Q | oabi-20250930.htm |
| 2025-09-17 | CORRESP | filename1.htm |
| 2025-09-12 | S-3 | d478991ds3.htm |
| 2025-09-10 | D | |
| 2025-08-25 | 8-K | d930006d8k.htm |
| 2025-08-06 | 10-Q | oabi-20250630.htm |
| Mr. Matthew W. Foehr | President, CEO & Director |
| Mr. Todd Pettingill C.F.A. | Vice President of Business Development & Strategy |
| Ms. Cia McCaffrey | Senior Vice President of People & Talent |